V. Jankūno klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 902,048 | 1,087,787 | 588,769 | 572,955 | 812,260 | 773,828 | 510,744 | 426,868 |
| Profit before tax | 404,214 | 469,498 | 279,196 | 113,488 | 155,592 | 133,456 | 11,257 | -55,158 |
| Net profit | 344,713 | 397,654 | 236,073 | 95,341 | 131,228 | 112,762 | 11,257 | -55,158 |
| Equity | 718,168 | 329,881 | 236,954 | 332,295 | 364,700 | 289,227 | 310,113 | 254,477 |
| Liabilities | - | - | - | - | 11,191 | 9,189 | 579,870 | 726,760 |
| Non-current assets | 76,285 | 54,096 | 31,536 | 121,723 | 184,886 | 146,065 | 577,432 | 843,147 |
| Current assets | 713,185 | 299,614 | 206,718 | 248,197 | 191,005 | 152,351 | 312,551 | 138,090 |
| Total assets | 789,470 | 353,710 | 238,254 | 369,920 | 375,891 | 298,416 | 889,983 | 981,237 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 144,293 | - | - |
| Social insurance contributions | - | - | - | - | - | - | - | 8,171 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +44.8% | +20.6% | -45.9% | -2.7% | +41.8% | -4.7% | -34.0% | -16.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 43.7% | 112.4% | 99.1% | 25.8% | 34.9% | 37.8% | 1.3% | -5.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 48.0% | 120.5% | 99.6% | 28.7% | 36.0% | 39.0% | 3.6% | -21.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 38.2% | 36.6% | 40.1% | 16.6% | 16.2% | 14.6% | 2.2% | -12.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 44.8% | 43.2% | 47.4% | 19.8% | 19.2% | 17.2% | 2.2% | -12.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.0 | 0.0 | 1.9 | 2.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 902,048 | 543,894 | 294,385 | 491,090 | 812,260 | 299,550 | 170,248 | 60,264 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
V. Jankūno klinika - Social security debts
The company had no debts to Sodra
V. Jankūno klinika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
V. Jankuno klinika, MB (code 303447486) is a small partnership engaged in medical specialists activities. In the latest financial year, 2025, revenue amounted to EUR 426.9K, which was 16.4% lower than in 2024 and 44.8% below the 2023 level. Profitability weakened over the period: net profit was EUR 112.8K in 2023, EUR 11.3K in 2024 and then fell to a net loss of EUR 55.2K in 2025. The 2025 profit margin was -12.9%.
The balance sheet continued to grow in 2025, with total assets of EUR 981.2K, equity of EUR 254.5K and liabilities of EUR 726.8K. Long-term assets increased to EUR 843.1K, while short-term assets were EUR 138.1K. Key ratios indicate weaker earnings and a higher debt load: ROE was -21.7%, ROA -5.6%, debt-to-equity 2.86 and asset turnover 0.44x. Revenue per employee was EUR 61.0K, while profit per employee was negative at EUR 7.9K.
The balance sheet continued to grow in 2025, with total assets of EUR 981.2K, equity of EUR 254.5K and liabilities of EUR 726.8K. Long-term assets increased to EUR 843.1K, while short-term assets were EUR 138.1K. Key ratios indicate weaker earnings and a higher debt load: ROE was -21.7%, ROA -5.6%, debt-to-equity 2.86 and asset turnover 0.44x. Revenue per employee was EUR 61.0K, while profit per employee was negative at EUR 7.9K.